Compare Inpatient Rehab examined data from the CDC's National Health Interview Survey to examine the chronic pain epidemic.
Fitgurú on MSN
Sitting all day? Experts say tight hip flexors could be the hidden cause of your back pain
Many people blame their chair, mattress, or posture for back pain—but health experts say a common muscle problem caused by ...
Discover evidence-based toothache relief, from cold compresses to clove oil. Learn when to see a dentist before it gets worse.
Some are afraid to move if it hurts. Some push too hard. Everyone agrees that exercise reduces chronic pain and enhances health — but how do you keep patients on track?
It’s a training roadblock that you’ve heard, or maybe experienced, time and time again – a runner suffering from pain in their leg. Unsurprisingly, thanks to the high-impact nature of our favourite ...
Spring Training has just begun, and yet hamate bone injuries have already impacted some of the biggest names in MLB. This week, we’ve learned that the Mets’ superstar shortstop Francisco Lindor and ...
A clinical trial at Brown University Health to treat chronic low back pain with a one-time, non-surgical injection treatment is seeking to enroll patients in Rhode Island. The trial is testing whether ...
Ghada Hatem-Gantzer, a French doctor, founded a one-stop shop to treat female victims of violence. Now, her revolutionary template is used across France. Dr. Ghada Hatem-Gantzer at the House of Women ...
Things that go bump in the flight. Soaring levels of turbulence have increasingly turned air travel into a real nightmare at 30,000 feet. Just last month, two people suffered broken ankles after a ...
When a house catches on fire, we assume that a smoke alarm inside will serve one purpose and one purpose only: warn the occupants of danger. But imagine if the device could transform into something ...
Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Get the AARP Now app. New and improved, it’s the app that makes ...
Shares of both Ultragenyx and Mereo BioPharma were seeing record selloffs after disappointing trial results for setrusumab Shares of Ultragenyx and Mereo BioPharma were rocked by disappointing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results